Related Experiment Videos
Client Participation per Round in Federated Learning for Multiple Sclerosis with Real-World Data
Ashkan Pirmani1,2,3, , Yves Moreau1
1ESAT - STADIUS, KU Leuven, Leuven, Belgium.
Studies in Health Technology and Informatics
|May 23, 2026
Summary
Federated learning for multiple sclerosis disability prediction shows that reducing client participation (k) shortens runtime. A participation rate of approximately 0.6 maintained high performance while significantly reducing computational time.
Area of Science:
- Artificial Intelligence
- Neuroscience
- Medical Informatics
Background:
- Federated learning (FL) enables collaborative machine learning without centralizing sensitive data.
- Predicting multiple sclerosis (MS) disability progression is crucial for patient management.
- Routine clinical data offers a valuable resource for developing predictive models.
Purpose of the Study:
- To investigate the impact of client participation rate (k) on federated learning performance and runtime.
- To evaluate the trade-offs between participation levels and model accuracy for predicting MS disability progression.
Main Methods:
- Utilized original study data, preprocessing, model architecture, and evaluation protocols.
- Varied the per-round client participation rate (k) to values of 1.0, 0.6, and 0.4.
- Assessed model performance using ROC-AUC and AUC-PR metrics and measured runtime.
Main Results:
- Lowering client participation (k) reduced computational wall time.
- A participation rate of k ≈ 0.6 maintained nearly all predictive performance (ROC-AUC and AUC-PR).
- Runtime was reduced by approximately one-third with k ≈ 0.6 compared to full participation (k=1.0).
Conclusions:
- Client participation rate is a critical parameter influencing federated learning efficiency.
- Optimizing k, such as to ≈ 0.6, offers a practical balance between runtime reduction and predictive accuracy in MS disability progression models.
- Federated learning with optimized participation is a viable approach for leveraging routine clinical data in neurological disease research.